ClinicalTrials.Veeva
Menu

Find clinical trials for Alzheimer's Disease in Houston, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Alzheimer Disease
Dementia
Cognitive Dysfunction
Mental Disorders
Brain Diseases
Nervous System Diseases
Neurodegenerative Diseases

Alzheimer's Disease trials near Houston, TX, USA:

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011)

This is a randomized, double-blind, sham-controlled, adaptive-design pivotal study of sensory stimulation in subjects with mild to moderate Alzheimer's...

Active, not recruiting
Alzheimer Disease 6
Dementia of Alzheimer Type
Device: Sensory Stimulation System (GS120) - Sham
Device: Sensory Stimulation System (GS120) - Active
Cognito Therapeutics
Cognito Therapeutics

Stafford, Texas, United States and 67 other locations

designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's...

Enrolling
Early Alzheimer's Disease
Drug: Placebo
Drug: CT1812

Phase 2

Cognition Therapeutics
Cognition Therapeutics

Houston, Texas, United States and 45 other locations

Study AACU determines rates of cognitive worsening in participants within elevated and not elevated plasma P-tau217 cohorts.Participation in AACU wil...

Not yet enrolling
Alzheimer Disease
Other: P-tau217 Test

Phase 3

Lilly
Lilly

Houston, Texas, United States and 1 other location

reason for this study is to collect safety and efficacy information regarding the study drug remternetug in participants with early symptomatic Alzheimer's...

Active, not recruiting
Alzheimer's Disease
Drug: Remternetug (SC)
Drug: Placebo

Phase 3

Lilly
Lilly

Houston, Texas, United States and 75 other locations

This 52-week, open-label extension study is to evaluate the long-term safety and tolerability of ACP-204 in subjects with ADP.

Invitation-only
Alzheimer's Disease Psychosis
Drug: ACP-204

Phase 3

Acadia Pharmaceuticals
Acadia Pharmaceuticals

Houston, Texas, United States and 50 other locations

is superior to placebo on change from baseline of the Preclinical Alzheimer Cognitive Composite 5 (PACC5) at 216 weeks of treatment (A45 Tri...

Active, not recruiting
Preclinical Alzheimer's Disease
Early Preclinical Alzheimer's Disease
Drug: Lecanemab
Drug: Placebo

Phase 3

Eisai
Eisai

Houston, Texas, United States and 109 other locations

Locations recently updated

This is a master protocol for 3 independent, seamlessly enrolling, multicenter, randomized, double-blind, placebo-controlled, parallel-group studies...

Enrolling
Alzheimer's Disease Psychosis
Drug: Placebo
Drug: ACP-204

Phase 2, Phase 3

Acadia Pharmaceuticals
Acadia Pharmaceuticals

Houston, Texas, United States and 126 other locations

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determin...

Active, not recruiting
Early Alzheimer's Disease
Drug: Lecanemab
Drug: Drug: Lecanemab

Phase 3

Eisai
Eisai

Houston, Texas, United States and 246 other locations

The aim of this study is to assess the efficacy and safety of GSK4527226 in participants with early Alzheimer's Disease (AD) (inclu...

Active, not recruiting
Alzheimer's Disease
Drug: GSK4527226
Other: Placebo

Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Houston, Texas, United States and 96 other locations

New

This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease...

Enrolling
Alzheimers Disease
Other: No Intervention

Phase 3

Roche
Roche

Houston, Texas, United States and 102 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems